Abstract
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: a subgroup analysis of the randomised clinical TITAN study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have